AI assistant
BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2016
Mar 2, 2016
30583_dirs_2016-03-02_5290fb7b-a01c-4139-8503-1ae3d201ae8d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2016-02-29
Reporting Person: BIENAIME JEAN JACQUES (Director, Chief Executive Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-02-29 | Common Stock | F | 192982 | $81.87 | Disposed | 350500 | Direct |
| 2016-03-01 | Common Stock | S | 5021 | $84.3259 | Disposed | 345479 | Direct |
| 2016-03-01 | Common Stock | S | 2151 | $84.2178 | Disposed | 343328 | Direct |
| 2016-03-01 | Common Stock | S | 2828 | $84.235 | Disposed | 340500 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 25758 | Indirect |
Footnotes
F1: Trade made pursuant to a 10b5-1 plan executed December 4, 2015.
F2: The price in column 4 is an average weighted price. The price actually received ranged from $81.35 to $87.11. The issuing person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F3: The price in column 4 is an average weighted price. The price actually received ranged from $81.40 to $86.61. The issuing person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.s.
F4: The price in column 4 is an average weighted price. The price actually received ranged from $81.50 to $86.98. The issuing person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.